Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole effect on irinotecan pharmacokinetics in cancer patients
NL-OMON28883Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of omeprazole and irinotecan in cancer, sponsored by Erasmus MC. Started Jan 2008; status: active, not recruiting.
02
Drugs
omeprazoleirinotecan
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON28883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28883.